1. Home
  2. LGCB vs VRAX Comparison

LGCB vs VRAX Comparison

Compare LGCB & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGCB

Linkage Global Inc

HOLD

Current Price

$1.99

Market Cap

23.4M

Sector

N/A

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.40

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGCB
VRAX
Founded
2011
2013
Country
Japan
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
2.9M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
LGCB
VRAX
Price
$1.99
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
58.7K
15.4M
Earning Date
07-03-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,993,265.00
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.80
N/A
52 Week Low
$1.22
$0.35
52 Week High
$6.83
$3.20

Technical Indicators

Market Signals
Indicator
LGCB
VRAX
Relative Strength Index (RSI) 51.41 41.24
Support Level $1.76 $0.39
Resistance Level $2.09 $0.43
Average True Range (ATR) 0.11 0.07
MACD -0.02 -0.01
Stochastic Oscillator 45.54 3.25

Price Performance

Historical Comparison
LGCB
VRAX

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: